FDA expands antidepressant warning to young adults
Story Highlights
• FDA expands antidepressant-suicidal thoughts warning to young adults
• Warning would apply to adults 18-24 during the first month or two of treatment
• Expert advisory panel recommended the change late last year
• Studies have not shown increased risk of suicidal thoughts in adults older than 24
WASHINGTON (AP) -- Young adults beginning treatment with antidepressants should be warned about an increased risk of suicidal thoughts and behavior, federal health officials said Wednesday.
The Food and Drug Administration proposed labeling changes that would expand a warning now on all antidepressants. The current language applies only to children and adolescents. The expanded warning would apply to adults 18-24 during the first month or two of treatment with the drugs, the FDA said.
The proposed label changes would apply to all antidepressants, brand names and generic forms as well.
